For Physicians
Company
Support
Sign in
Register
Home
Ophthalmology
Question
How often and in what way do you monitor patients who are receiving teprotumumab (Tepezza) for thyroid eye disease?
2
1 Answers
Add Answer
Mednet Member
Ophthalmology · Jackson Eye Associates
A week or two after completion unless having an issue.
Register
or
Sign In
to see full answer
